Lipid infusions to improve nutrition for premature babies
Part of Genetic & congenital, Lungs & breathing clinical trials.
This trial tests whether giving fat (lipid) infusions can improve nutrition and growth in very premature or very low birth weight babies. It may be for babies born before 28 weeks or weighing 1,000 grams or less.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is born before 28 weeks of pregnancy.
- Or your baby weighs 1,000 grams (about 2.2 pounds) or less at birth.
- Your baby survives at least 12 hours after birth.
- Your baby can be enrolled within the first 96 hours (4 days) after birth.
- Your baby does not have a major birth defect, a clear non-bacterial infection, or a condition where intensive care is being limited or withdrawn.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether feeding extremely premature babies (born at 28 weeks or earlier) a higher-energy breast milk diet in the first two weeks of life can reduce the risk of bronchopulmonary dysplasia (BPD), a serious lung condition. It aims to find a safe and effective way to support lung development in these tiny infants.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
This trial tests a medicine called zelpultide alfa in very premature babies who are at high risk of developing bronchopulmonary dysplasia (BPD), a chronic lung disease. The goal is to see if it can help prevent or lessen lung problems compared to standard care alone.
This trial tests if intravenous immunoglobulin (IVIG) can help prevent or treat bronchopulmonary dysplasia (BPD), a lung condition in premature babies. It is for very preterm infants born between 25 and 29 weeks who show early signs of BPD and are enrolled in the first day of life.
This trial tests whether giving intravenous immunoglobulin (IVIG) early after birth can help prevent or treat a serious lung condition called bronchopulmonary dysplasia (BPD) in babies born at 28 weeks or earlier. It may help reduce the need for breathing support and oxygen.
This trial tests if stem cells can help premature babies with severe lung disease (bronchopulmonary dysplasia). It is for very small, early-born babies who still need a breathing machine between 5 and 14 days after birth.
Hear when a new Bronchopulmonary Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.